IP Library Patent Application 13018258
Patent Application
App. No. 13/018,258

PATIENT-CONTROLLED AEROSOL ADMINISTRATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/018,258
Abstract

A system and method of controlling the administration of a medical substance is disclosed. An aerosol generator is configured to aerosolize a medical substance and administer the aerosolized medical substance to a patient using a ventilator. The patient is provided with a patient control interface through which the patient initiates the administration of a dose of the aerosolized medical substance. A processor is configured to control the ventilator and the aerosol generator in response to the patient control interface such that the patient controls the administration of the aerosolized medical substance in accordance with limits on the administration of the medical substance.

Claims (49)

1 . A method of controlling the administration of a medical substance, the method comprising the steps of:

configuring an aerosol generator to aerosolize a medical substance and administer the aerosolized medical substance to a patient using a ventilator;

providing the patient with a patient control interface through which a patient initiates the administration of a dose of the aerosolized medical substance; and

configuring a processor to control the ventilator and the aerosol generator in response to the patient control interface such that the patient controls the administration of the aerosolized medical substance in accordance with limits on the administration of the medical substance.

2 . The method of claim 1 , wherein the step of configuring the processor further comprises specifying a lock-out time period such that a dose of the aerosolized medical substance is administered only after the lock-out time period has elapsed since the last prior administration of the aerosolized medical substance.

3 . The method of claim 2 , further comprising the step of displaying the amount of time remaining in the lock-out period.

4 . The method of claim 1 , wherein the medical substance is a medication.

5 . The method of claim 1 , further comprising the step of measuring at least one monitored parameter that is associated with the health of the patient, and wherein the step of configuring the processor further comprises specifying at least one limit for the at least one monitored parameter such that a dose of the aerosolized medical substance is administered only when the at least one monitored parameter is within the at least one limit.

6 . The method of claim 1 , wherein the step of configuring the processor further comprises selecting a dosage range such that the patient uses the patient control interface to vary the dose of the aerosolized medical substance to be administered within the dose range.

7 . The method of claim 1 , further comprising the steps of:

measuring at least one health parameter that is associated with the current health of the patient; and

displaying the at least one health parameter.

8 . A ventilation system for use by a patient, comprising:

a patient device attached to the patient, the patient device configured to introduce gas into the lungs of the patient;

a gas control module fluidically coupled to the patient device, the gas control module configured to controllably provide a gas to the patient device according to at least one operating parameter;

an aerosol generator coupled to the patient device, the aerosol generator configured to administer a dose of an aerosolized medical substance;

a patient control interface configured to control the at least one operating parameter of the gas control module and to be accessible by the patient; and

a processor coupled to the gas control module, the aerosol generator, and the patient control interface, the processor configured to operate the gas control module and the aerosol generator in response to the patient control interface.

9 . The ventilation system of claim 8 , wherein:

the gas control module is configured to measuring a health parameter that is associated with the health of the patient;

the patient control interface is further configured to display the health parameter.

10 . The ventilation system of claim 8 , further comprising a memory coupled to the processor, the memory configured to store one or more executable instructions, wherein the processor is further configured to retrieve the instructions from the memory and operate the gas control module and the aerosol generator in accordance with the retrieved instructions.

11 . The ventilation system of claim 8 , wherein:

the gas control module is configured to measuring a health parameter that is associated with the health of the patient;

the aerosol generator is further configured to administer the aerosolized medical substance only if the measured health parameter is within present limits.

12 . The ventilation system of claim 8 , wherein the aerosol generator is further configured to administer a dose of the aerosolized medical substance only after a specified lock-out time period has elapsed since the last prior administration of the aerosolized medical substance.

13 . A computer-readable medium having computer-executable instructions stored thereon for execution by a processor to perform a method of controlling the administration of a medical substance, the method comprising the steps of:

configuring an aerosol generator to aerosolize a medical substance and administer the aerosolized medical substance to a patient using a ventilator;

providing the patient with a patient control interface through which a patient initiates the administration of a dose of the aerosolized medical substance; and

configuring a processor to control the ventilator and the aerosol generator in response to the patient control interface such that the patient controls the administration of the aerosolized medical substance in accordance with limits on the administration of the medical substance.

14 . The computer-readable medium of claim 13 , wherein the step of configuring the processor further comprises specifying a lock-out time period such that a dose of the aerosolized medical substance is administered only after the lock-out time period has elapsed since the last prior administration of the aerosolized medical substance.

15 . The computer-readable medium of claim 14 , further comprising the step of displaying the amount of time remaining in the lock-out period.

16 . The computer-readable medium of claim 13 , wherein the medical substance is a medication.

17 . The computer-readable medium of claim 13 , further comprising the step of measuring at least one monitored parameter that is associated with the health of the patient, and wherein the step of configuring the processor further comprises specifying at least one limit for the at least one monitored parameter such that a dose of the aerosolized medical substance is administered only when the at least one monitored parameter is within the at least one limit.

18 . The method of claim 13 , wherein the step of configuring the processor further comprises selecting a dosage range such that the patient uses the patient control interface to vary the dose of the aerosolized medical substance to be administered within the dose range.

19 . The method of claim 13 further comprising the steps of:

measuring at least one health parameter that is associated with the current health of the patient; and

displaying the at least one health parameter.

20 . A method of controlling the administration of a medical substance to a patient using a ventilator, the method comprising the steps of:

configuring an aerosol generator to aerosolize a medical substance and administer the aerosolized medical substance to the patient;

providing the patient with a patient control interface through which a patient initiates the administration of a dose of the aerosolized medical substance; and

configuring a processor to control the aerosol generator in response to the patient control interface such that the patient controls the administration of the aerosolized medical substance in accordance with limits on the administration of the medical substance.

21 . A ventilator controller configured to control a ventilator, comprising:

an aerosol generator configured to couple to a patient device that is configured to introduce gas into the lungs of the patient, wherein the patient device is also coupled to a ventilator, the aerosol generator further configured to administer a dose of an aerosolized medical substance;

a memory configured to store one or more executable instructions and data;

a patient control interface configured to initiate administration of a dose of an aerosolized medical substance and to be accessible by the patient; and

a processor coupled to the aerosol generator, the memory, and the patient control interface, the processor configured to retrieve the instructions and data from the memory and operate the aerosol generator in response to the patient control interface.

22 . The ventilator controller of claim 21 , wherein the processor is further configured to be coupled to the ventilator and to modify the operation of the ventilator when a dose of the aerosolized medical substance is being administered.

23 . The ventilator controller of claim 21 , wherein the processor is further configured to administer a dose of the aerosolized medical substance only after a specified lock-out time period has elapsed since the last prior administration of the aerosolized medical substance.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2018
From: CITIZENS BANK, N.A.
To: VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC; CAREFUSION 202, INC.; VITAL SIGNS, INC.
Reel/Frame 045779/0035 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2016
From: CAREFUSION 303, INC.
To: CAREFUSION 2200, INC.
Reel/Frame 040372/0854 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2016
From: CAREFUSION 2200, INC.
To: KINGSTON RESPIRATORY 102 LLC
Reel/Frame 040372/0903 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2016
From: KINGSTON RESPIRATORY 102 LLC
To: KINGSTON RESPIRATORY CAPITAL LLC
Reel/Frame 040372/0963 →
CHANGE OF NAME Recorded Nov 18, 2016
From: KINGSTON RESPIRATORY CAPITAL LLC
To: VYAIRE MEDICAL CAPITAL LLC
Reel/Frame 040652/0311 →
SECURITY AGREEMENT Recorded Oct 14, 2016
From: VYAIRE MEDICAL CAPITAL LLC; VYAIRE MEDICAL CONSUMABLES LLC; VITAL SIGNS, INC.; CAREFUSION 202, INC.
To: CITIZENS BANK, N.A, AS COLLATERAL AGENT
Reel/Frame 040357/0952 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2011
From: LEWIS, STEPHEN; WESTFALL, THOMAS; BLANSFIELD, TERRY
To: CAREFUSION 303, INC.
Reel/Frame 025905/0024 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2011
From: LEWIS, STEPHEN; WESTFALL, THOMAS; BLANSFIELD, TERRY
To: CAREFUSION 303, INC.
Reel/Frame 025784/0225 →